Why a mail machine company is a good investment. Plus: TD Ameritrade is benefiting from the return of the retail investor, and Pfizer is better off without AstraZeneca.
[grabpress_video guid=c4fdddfa6d6cb5c89fa48caf50a1de4c4048dec1 embed_id=2085735]
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark our homepage.